Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 364

Results For "low"

3886 News Found

Machine Learning to understand and prevent disease
Digitisation | September 17, 2021

Machine Learning to understand and prevent disease

Barbara Engelhardt moves her computational and statistics lab to Gladstone


Novavax to participate in Oxford university’s study on combining Covid-19 vaccines
Biotech | September 17, 2021

Novavax to participate in Oxford university’s study on combining Covid-19 vaccines

Study to explore heterologous regimen of COVID-19 vaccines from different manufacturers in adolescents 12-16 years of age


Unum designs vaccine verification tool to track Covid-19 vaccination status
Digitisation | September 17, 2021

Unum designs vaccine verification tool to track Covid-19 vaccination status

It will also manage test result documentation for employees who are not vaccinated, sending weekly reminders and employer notification


Allianz Partners expands its Digital Health Assistant to India
Digitisation | September 16, 2021

Allianz Partners expands its Digital Health Assistant to India

Initially launched in Europe, this new service gives customers access to a range of digital health services and medical professionals and is part of its Digital Access to Care Initiative


U.S. FDA approves Thermo Fisher Scientific’s Oncomine Dx target test
Medical Device | September 16, 2021

U.S. FDA approves Thermo Fisher Scientific’s Oncomine Dx target test

It approves tissue-based NGS companion diagnostic for Takeda's targeted therapy for NSCLC patients with EGFR Exon20 insertion mutations


Glenmark’s PMS study allays concerns on use of Favipiravir for Covid-19 treatment
News | September 15, 2021

Glenmark’s PMS study allays concerns on use of Favipiravir for Covid-19 treatment

These were the findings of the Post Marketing Surveillance (PMS), study of Favipiravir (FabiFlu) on over 1000 patients


World’s first clinical trial for a rare headache disorder
Biotech | September 15, 2021

World’s first clinical trial for a rare headache disorder

The trial will evaluate the efficacy of psilocybin in Short-lasting Unilateral Neuralgiform Headache Attacks (SUNHA). The data is expected in early 2022


ICMR to use drones for vaccine delivery
Supply Chain | September 14, 2021

ICMR to use drones for vaccine delivery

ICMR receives conditional exemption from Drone Rules 2021 to speed up vaccine delivery in the A&N Islands, Manipur and Nagaland


BDR Pharmaceuticals launch Cabozantinib to treat thyroid cancer
Drug Approval | September 14, 2021

BDR Pharmaceuticals launch Cabozantinib to treat thyroid cancer

In several trials like Celestial (double-blind phase III trial), Phase III Meteor trials, Cabozantinib has shown better PFS (Progression-Free Survival).


ENTOD Pharma launches surgical division HyTek
Medical Device | September 14, 2021

ENTOD Pharma launches surgical division HyTek

The division will focus on products that are required during ophthalmic surgical procedures like cataracts and refractive surgeries among others